HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.

AbstractThe anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to > or =10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
AuthorsV A Semenova, D S Schmidt, T H Taylor Jr, H Li, E Steward-Clark, S D Soroka, M M Ballard, C P Quinn (Affiliation: Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. vsemenova at cdc.gov)
JournalVaccine (Vaccine) Vol. 25 Issue 10 Pg. 1780-8 (Feb 26 2007) ISSN: 0264-410X [Print] Netherlands
PMID17229495 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anthrax Vaccines
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Antitoxins
  • Bacterial Toxins
  • Immunoglobulin G
  • anthrax toxin
Topics
  • Adult
  • Aged
  • Anthrax (immunology)
  • Anthrax Vaccines (immunology)
  • Antibodies, Bacterial (blood, classification)
  • Antigens, Bacterial (immunology)
  • Antitoxins (blood)
  • Bacterial Toxins (immunology)
  • Female
  • Humans
  • Immunoglobulin G (blood, classification)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD